Data from the U.S. Department of Health and Human Services Medicaid Provider Spending database show that Medicaid payments for services identified by COVID-19–related HCPCS codes in Marlborough amounted to at least $617,627 in 2024.
Medicaid, a public health insurance program administered by the states with joint federal and state funding, covers low-income people and families, seniors, children, and individuals with disabilities. This makes it a key component of the U.S. health care system. For more, see the Commonwealth Fund explainer.
Since Medicaid is funded by taxpayers, changes in local billing indicate how public health care resources are distributed within a community.
For this report, COVID-19–related services were defined using HCPCS codes marked as “COVID-19” or “coronavirus” in billing descriptions or classification data. As such, figures only reflect services directly identified as COVID-19–related and do not include care associated with the pandemic billed under broader or other medical codes.
By comparison, Boston had the most Medicaid payments tied to COVID-19 services statewide for 2024, with virus-related billings totaling $691,711.
In Marlborough, four providers billed Medicaid for COVID-19–coded services in 2024. The code COVID Specific was most frequently billed, accounting for $615,191.
To provide additional context, the average Medicaid payment per provider for COVID-19–coded services in Marlborough reached $154,407, which exceeds the state average of $28,676.
During the main pandemic years, COVID-19–specific billings represented a significant factor in Medicaid spending increases in Marlborough.
Overall Medicaid payments for all other claims in Marlborough grew by $27,913,452 from 2020 to 2024, marking a 37.7% rise.
In the two years prior to the pandemic, Marlborough reported average annual Medicaid payments of $94,210,150.
According to the Centers for Medicare & Medicaid Services, combined federal and state Medicaid spending reached approximately $871.7 billion in fiscal year 2023, making up nearly 18% of all national health expenditures. This is a notable increase from $613.5 billion in 2019, prior to the COVID-19 pandemic.
The data indicate about 40% growth over several years, primarily due to growing enrollment and higher usage during and following the pandemic.
Recent federal budget measures, including legislation enacted during the Trump administration, have proposed major reductions to federal Medicaid funding and changes to program structure. Specifically, the “One Big Beautiful Bill Act,” enacted in 2025, is expected to reduce federal Medicaid expenditures by over $1 trillion over the next ten years while introducing policies like work requirements and higher cost-sharing that could affect coverage and funding for certain beneficiaries. These policy shifts are likely to move more financial responsibility to states and restrain growth in federal Medicaid support, even as the program serves millions across the country.
| Year | COVID-19–Related Payments | COVID-19 Payments % Change (YoY) | Total Medicaid Payments |
|---|---|---|---|
| 2024 | $617,627 | -65.5% | $102,527,412 |
| 2023 | $1,792,734 | -84.7% | $110,158,614 |
| 2022 | $11,722,147 | -60.4% | $112,360,438 |
| 2021 | $29,585,683 | 55.4% | $114,766,678 |
| 2020 | $19,041,129 | N/A | $93,037,462 |
| 2019 | $0 | N/A | $94,463,289 |
| 2018 | $0 | N/A | $93,957,010 |
| HCPCS Code | Description | Medicaid Payments | Claims |
|---|---|---|---|
| 87635 | COVID Specific | $615,191 | 13,292 |
| 87811 | Immunoassay | $2,436 | 201 |
| U0002 | COVID Specific | $0 | 16 |
Note: Figures only include HCPCS codes explicitly designated for COVID-19 services, and do not represent total health care spending related to the pandemic.
This article used information from the U.S. Department of Health and Human Services Medicaid Provider Spending database. Source data are available here.










